The nation of Zimbabwe has rejected a major American healthcare agreement worth $367m (£272m) spanning five years over Washington's demand for sensitive information.
This rejection came to light after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesman later stated that the United States was requesting health data for research and profit but refused to guarantee the benefits from future vaccines.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged further dialogue to find a agreement agreeable to all parties so the country's critical HIV programme can proceed.
Broader Implications
This rejection comes after a similar situation in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the safety of citizens' medical information.
After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and accountability.
As per statements, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our nation would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our citizens should a new health crisis arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems already established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This mechanism is designed to ensure that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
These objections regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how future co-operation could be structured in a way that respects the independence and dignity of each country."
Medical Community Response
A leading public health body stated it acknowledged the government's concerns, but urged that talks must proceed since a large portion of the nation's HIV programmes depended on international support.
"In cases where specific concerns exist, including those relating to data governance or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," the group added.
This impasse highlights the ongoing tensions between receiving crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.